China NMPA Drug Inspection - Sinopharm Group Zhijun (Shenzhen) Pharmaceutical Co., Ltd. - Cefuroxime sodium for injection
China NMPA drug inspection for Sinopharm Group Zhijun (Shenzhen) Pharmaceutical Co., Ltd. published August 24, 2018. Drug: Cefuroxime sodium for injection. The National Medical Products Administration (NMPA) of China issued Announcement No. 77 on August 24, 2018, detailing no
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Sinopharm Group Zhijun (Shenzhen) Pharmaceutical Co., Ltd. published August 24, 2018. Drug: Cefuroxime sodium for injection. The National Medical Products Administration (NMPA) of China issued Announcement No. 77 on August 24, 2018, detailing no
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox